Is Sana Biotechnology profitable?

Sana Biotechnology is not currently profitable: it reported a net loss of $242.0M over the trailing twelve months.

What is Sana Biotechnology's earnings per share?

Sana Biotechnology's diluted EPS over the trailing twelve months is $-0.93.

Where does Sana Biotechnology's income statement data come from?

Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Sana Biotechnology SANA Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Research and development	$28.72M-22.8%	$34.92M-22.6%	$30.11M-43.4%	$29.76M-51.1%	$37.19M-34.1%
General and administrative	$11.46M-0.2%	$12.19M-29.5%	$10.29M-26.8%	$10.34M-37.1%	$11.48M-29.4%
Other operating expenses	$48.61M-4.0%	$61.2M+20.3%	$43.52M-29.5%	$94.98M+92.4%	$50.63M-54.3%
Total operating expenses	$48.61M-4.0%	$61.2M+20.3%	$43.52M-29.5%	$94.98M+92.4%	$50.63M-54.3%
Operating income	-$48.61M+4.0%	-$61.2M-20.3%	-$43.52M+29.5%	-$94.98M-92.4%	-$50.63M+54.3%
Interest expense	$951K-4.1%	$1.28M-22.9%	$1M-61.1%	$577K-82.0%	$992K-67.3%
Other income (expense), net	$453K+81.9%	$1.1M—	$360K+149%	$598K+115%	$249K+15.8%
Net income	-$47.21M+4.4%	-$58.83M-19.9%	-$42.15M+29.7%	-$93.8M-86.5%	-$49.39M+54.0%
Diluted earnings per share	-$0.17+19.0%	-$0.210.0%	-$0.16+36.0%	-$0.39-85.7%	-$0.21+57.1%
Basic earnings per share	-$0.17+19.0%	-$0.210.0%	-$0.16+36.0%	-$0.39-85.7%	-$0.21+57.1%
Weighted-average shares, diluted	276.9M+16.5%	253.2M+9.7%	260.5M+10.7%	238.4M+1.7%	237.6M+9.3%
Weighted-average shares, basic	276.9M+16.5%	253.2M+9.7%	260.5M+10.7%	238.4M+1.7%	237.6M+9.3%
Interest Income (Expense), Nonoperating	$951K-4.1%	$1.28M-22.9%	$1M-61.1%	$577K-82.0%	$992K-67.3%
Other income, net (Note 6)	$453K+81.9%	$1.1M—	$360K+149%	$598K+115%	$249K+15.8%
Research And Development Related Success Payments And Contingent Consideration	$8.43M+331%	$14.09M+205%	$3.12M+157%	$10.26M+137%	$1.96M-94.9%
EBIT	-$48.61M+4.0%	-$61.2M-20.3%	-$43.52M+29.5%	-$94.98M-92.4%	-$50.63M+54.3%
EBITDA	-$46.22M+1.6%	——	-$40.32M+30.1%	-$92.08M-102%	-$46.98M+56.1%
EBITDA	-$46.22M+1.6%	——	-$40.32M+30.1%	-$92.08M-102%	-$46.98M+56.1%
EBIT	-$48.61M+4.0%	-$61.2M-20.3%	-$43.52M+29.5%	-$94.98M-92.4%	-$50.63M+54.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Sana Biotechnology profitable?: Sana Biotechnology is not currently profitable: it reported a net loss of $242.0M over the trailing twelve months.
What is Sana Biotechnology's earnings per share?: Sana Biotechnology's diluted EPS over the trailing twelve months is $-0.93.
Where does Sana Biotechnology's income statement data come from?: Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.